Navigation Links
Althea Technologies Announces Appointment of Rick Hancock as President
Date:11/10/2010

SAN DIEGO, Nov. 11, 2010 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of contract development and manufacturing services for biopharmaceutical and parenteral products, announced today that Rick Hancock has been appointed President of the company.  Mr. Hancock brings twenty-seven years of industry experience and detailed working knowledge of Althea's operations to lead the company into the future.  Mr. Hancock will lead the company's expansion of its clinical and commercial contract manufacturing services.

(Logo:  http://photos.prnewswire.com/prnh/20020925/LAW010LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

Dr. Magda Marquet, Co-Founder and Co-Chairman of the Board, commented, "I am very confident that Rick's proven track record and leadership style will be integral to Althea's growth and success as we continue to expand our business into commercial operations.  I am delighted to see Rick appointed as President."

Mr. Hancock was Althea's Chief Operating Officer from 1998 to 2007. In addition, he served as Althea's Executive Vice President, Europe to expand Althea's global presence. During his tenure as Althea's COO, Rick was instrumental in growing the company from a small group of scientists and manufacturing staff to a leading contract manufacturing organization.  In addition, Mr. Hancock has a very strong background in process development and GMP manufacturing dating back to his tenure at Hybritech, The Immune Response Corporation and Genetics Institute.

Commenting on the contributions of his predecessor, Mr. Hancock said, "I'm very appreciative for all the systems and improvements that Dr. Shabbir Anik put in place at Althea over the past two years.  His efforts have helped build an infrastructure that provides an excellent foundation for our anticipated growth and expansion."  

Matt Mackowski, Co-Chairman of the Board and Chairman of Telegraph Hill Partners, commented, "I am confident that Rick's strengths in building top-performing teams combined with Althea's technical depth and broad development and manufacturing capabilities will both delight our customers and build upon Althea's recognition as the West Coast's premier Biologics CMO."  

Mr. Hancock added, "I'm honored to work with such an experienced and qualified management team; we all look forward to continuing to provide our customers with outstanding services."

About Althea Technologies, Inc.

Althea Technologies is a fully integrated, contract development and manufacturing organization that provides services for plasmid DNA, recombinant proteins, and sterile products. Located in San Diego, CA, Althea offers cell banking, process development, cGMP protein & plasmid production, analytical development, formulation and lyophilization development, and aseptic filling in vials & prefilled syringes for clinical development and commercialization.  Althea's formulation technology platform employs crystalomics that can be applied to a variety of peptides and proteins for high concentration or sustained release formulations.  For more information, visit www.altheatech.com.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
2. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
3. Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
8. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
9. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
10. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
11. Senesco Technologies Initiates Preclinical Studies for Cancer Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 Ascendis Pharma ... innovative TransCon technology to address significant unmet medical needs ... host a conference call and webcast on Monday, April ... Endocrine Society in Orlando, Florida , ... pipeline candidates (TransCon Growth Hormone, TransCon PTH and TransCon ...
(Date:3/23/2017)... DIEGO , March 23, 2017  A ... fast and accurate identification of individuals who carry ... risk for a rare yet potentially deadly side ... and bipolar disorder.  The gene HLA-B*15:02 ... reactions such as Stevens-Johnson syndrome and toxic epidermal ...
(Date:3/23/2017)... Prima BioMed has presented encouraging ... IMP321 in combination with Keytruda, with one of the ... a complete response. Recruitment in the second cohort is ... fully recruited by Q317. Preliminary efficacy data from the ... are expected mid-year (recruitment in the 226-patient Phase IIb ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... now offering treatments for sleep apnea and TMJ at their office. TMJ, or ... , specifically the obstructive type, is increasingly being treated at dental offices with ...
(Date:3/24/2017)... ... March 24, 2017 , ... Viewers who like to educate ... historical facts, cultural practices, goods, services, and societal issues tend to appreciate and love ... the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, ... Master in Frederick, MD. Judy says, “I am passionate about sharing Reiki as ... a very difficult and challenging time.” , A Certified Medical Reiki™ Master trained ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian ... Bible teacher residing in North Carolina with his wife, Anna Marie. He and his ... six grandchildren. David is also the author of “Shadow and Substance.” , “Love, the ...
(Date:3/23/2017)... , ... March 23, 2017 , ... In 2016 the ... estimates that there could be four million Zika-related cases in the Americas within the ... numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, ...
Breaking Medicine News(10 mins):